Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name VLS-101
Trade Name
Synonyms VLS 101|VLS101|Zilovertamab Vedotin|MK 2140|MK2140|MK-2140
Drug Descriptions

VLS-101 is an antibody-drug conjugate (ADC) comprising a ROR1-targeted antibody linked to monomethyl auristatin E (MMAE), which delivers the drug to ROR1-expressing tumor cells, potentially resulting in increased apoptosis and decreased tumor growth (Blood (2019) 134 (Supplement_1): 2856).

DrugClasses ROR1 Antibody 5
CAS Registry Number 2376463-48-6
NCIT ID C157772

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ARQ 531 + VLS-101 ARQ 531 VLS-101 0 1
Bendamustine + Rituximab + VLS-101 Bendamustine Rituximab VLS-101 0 1
Cyclophosphamide + Doxorubicin + Rituximab + VLS-101 Cyclophosphamide Doxorubicin Rituximab VLS-101 0 1
Gemcitabine + Oxaliplatin + Rituximab + VLS-101 Gemcitabine Oxaliplatin Rituximab VLS-101 0 1
VLS-101 VLS-101 0 5


Additional content available in CKB BOOST